These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27000759)

  • 1. Author's reply to Veloso HH Comment on "The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm".
    Jelliffe RW
    Clin Pharmacokinet; 2016 May; 55(5):637-9. PubMed ID: 27000759
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: "The Role of Digitalis Pharmacokinetics in Converting Atrial Fibrillation and Flutter to Sinus Rhythm".
    Veloso HH
    Clin Pharmacokinet; 2016 May; 55(5):635-6. PubMed ID: 27000760
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of digitalis pharmacokinetics in converting atrial fibrillation and flutter to regular sinus rhythm.
    Jelliffe RW
    Clin Pharmacokinet; 2014 May; 53(5):397-407. PubMed ID: 24671885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of conversion to sinus rhythm using ibutilide for atrial fibrillation or flutter.
    Zaqqa M; Afshar H; Rasekh A; Khoshnevis R; Vaughn WK; Massumi A
    Am J Cardiol; 2000 Jan; 85(1):112-4, A9. PubMed ID: 11078250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation].
    Vainer J; Smíd J; Cepeláková H; Hapala J; Topinka I; Topolcan O
    Vnitr Lek; 1989 Feb; 35(2):145-50. PubMed ID: 2711622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter].
    Vergara G
    Ital Heart J Suppl; 2001 Mar; 2(3):322-3. PubMed ID: 11307794
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic conversion of atrial fibrillation and atrial flutter to normal sinus rhythm: the role of ibutilide.
    Katcher MS; Estes NA
    Pharmacotherapy; 1997; 17(1):177-80. PubMed ID: 9017781
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of physical activity on serum concentrations of digoxin and digitoxin.
    Grille W; Welter U; Johnsen K; Kolenda KD; Löffler H
    Eur J Clin Pharmacol; 1996; 50(3):237-9. PubMed ID: 8737766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic pharmacologic therapy for atrial fibrillation and flutter.
    Khouzam S; Kirk M
    Med Health R I; 2004 Apr; 87(4):104-7. PubMed ID: 15168635
    [No Abstract]   [Full Text] [Related]  

  • 11. The relation of quinidine-induced elevation of serum digoxin concentration to the conversion of atrial fibrillation-flutter: a pilot study.
    Shah S; Friedman HS
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):929-30. PubMed ID: 2487553
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter.
    Roberts SA; Diaz C; Nolan PE; Salerno DM; Stapczynski JS; Zbrozek AS; Ritz EG; Bauman JL; Vlasses PH
    Am J Cardiol; 1993 Sep; 72(7):567-73. PubMed ID: 8362772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reconversion of long-standing atrial flutter and fibrillation to sinus rhythm, with oral verapamil and digoxin. Description of 3 cases].
    Mazzoli V; Malmusi A; Scalori G
    G Clin Med; 1985; 66(1-2):57-61. PubMed ID: 4007343
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conversion of atrial fibrillation and flutter by a combination of anti-arrhythmic drugs].
    Pidrman V; Hamet A
    Vnitr Lek; 1972 Sep; 18(9):845-8. PubMed ID: 4403993
    [No Abstract]   [Full Text] [Related]  

  • 16. Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group.
    Benditt DG; Williams JH; Jin J; Deering TF; Zucker R; Browne K; Chang-Sing P; Singh BN
    Am J Cardiol; 1999 Aug; 84(3):270-7. PubMed ID: 10496434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atrial fibrillation and flutter in children].
    Battaglia T; Attanà A; Fumarulo A; Paparo F; Primerano M; Martini B
    Minerva Med; 1982 Apr; 73(14):855-8. PubMed ID: 7070698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of paroxysmal forms of auricular fibrillation and atrial flutter in a cardiological hospital].
    Uzilevskaia RA; Grishkin IuN
    Kardiologiia; 1983 Feb; 23(2):81-5. PubMed ID: 6842954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Selection Is Critical in Rate or Rhythm Control of Atrial Fibrillation or Flutter.
    Yeh YT; Li AH; Wu YW
    Ann Emerg Med; 2015 Nov; 66(5):562-3. PubMed ID: 26497439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.